External validation revealed that the causal relationship between CSF FCG2B and SLE was successfully replicated in the 2 external datasets of SLE, and that plasma ICAM-1 was validated only in the GWAS summary statistics,[23] which further demonstrated the confidence of the potential drug targets identified in this study. The gene discussed is ICAM1; the disease is systemic lupus erythematosus.